Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
specificMalignant glioma that does not respond to treatment.
6
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 58.3 |
| 2 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 58.3 |
| 3 | NCI Comprehensive | 58.3 |
| 4 | University of Illinois Cancer CenterChicago, IL | 58.3 |
| 5 | Boston University Cancer CenterBoston, MA | 58.3 |
| 6 | Cancer Center at IllinoisUrbana, IL | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →